GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

GlaxoSmithKline Pakistan Revenue

GlaxoSmithKline Pakistan had revenue of 16.59B PKR in the quarter ending September 30, 2026, with 16.96% growth. This brings the company's total for the last twelve months to 69.53B, up 12.00% year-over-year. In the year 2025, GlaxoSmithKline Pakistan had annual revenue of 65.90B with 7.70% growth. That makes GlaxoSmithKline Pakistan the 15,787th largest company in the world by revenue and 81st in Pakistan.

• Revenue (ttm): 69.53B
• Revenue Growth: +12.00%
• P/S Ratio: 1.56
• Revenue / Employee: 43.29M
• Employees: 1,606
• Market Cap: 107.42B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Pakistan 66.44B 99.8%
• Unallocated Commissions, Returns and Discounts 98.99M 0.1%
• Export 13.46M 0.0%

Fiscal year ended Dec 31, 2025 See the full GlaxoSmithKline Pakistan breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	65.90B	4.71B	7.70%
Dec 31, 2024	61.19B	11.53B	23.21%
Dec 31, 2023	49.66B	7.82B	18.69%
Dec 31, 2022	41.84B	5.18B	14.13%
Dec 31, 2021	36.66B	1.57B	4.48%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error